AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS · Delayed Price · Currency is USD
0.0130
-0.0010 (-7.14%)
Feb 12, 2026, 1:37 PM EST
AXIM Biotechnologies Market Cap
AXIM Biotechnologies has a market cap or net worth of $4.63 million as of February 13, 2026. Its market cap has increased by 437.30% in one year.
Market Cap
4.63M
Enterprise Value
11.40M
Revenue
92.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since October 9, 2013, AXIM Biotechnologies's market cap has increased from 1.98M to 4.63M, an increase of 133.65%. That is a compound annual growth rate of 7.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.63M | 21.58% |
| Dec 31, 2025 | 3.81M | 528.02% |
| Dec 31, 2024 | 605.90K | -86.58% |
| Dec 29, 2023 | 4.52M | -12.57% |
| Dec 30, 2022 | 5.16M | -91.35% |
| Dec 31, 2021 | 59.71M | 10.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 6.46M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |
| Enzon Pharmaceuticals | 5.33M |
| Clearside Biomedical | 5.10M |
| Nymox Pharmaceutical | 4.23M |